Table 6. Effectiveness of montelukast compared to placebo in the non-atopic eczema group.
Changes after taking Montelukast (Mean±SD) |
Changes after taking Placebo drug (Mean±SD) |
P value | |
---|---|---|---|
SCORAD index | 0.7±13.7 | -2.7±12.6 | 0.62 |
Urine LTE4 (pg/mL) | -174.1± 596.5 | 127.4±562.3 | 0.18 |
Urine EDN (ng/mL) | -152.0±907.3 | -484.7±780.6 | 0.31 |
SCORAD, SCORing Atopic Dermatitis; LTE4, leukotriene E4; EDN, eosinophil-derived neurotoxin.